Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS–Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and China

BACKGROUND AND OBJECTIVE: Irritable Bowel Syndrome (IBS) has a substantial impact on health-related quality of life (HR-QoL) but high-quality data pre- and post-treatment using the IBS–Quality of Life (IBS-QOL) measure are limited. The objective of this study was to evaluate the changes from baselin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Xiaohua, Chen, Shengliang, Zhang, Yali, Sha, Weihong, Yu, Xiaofeng, Elsawah, Hesham, Afifi, Afifi Fahmy, El-Khayat, Hisham Raafat, Nouh, Alaa, Hassan, Mohamed Fathalla, Fatah, Ayman Abdel, Rucker Joerg, Isabel, Sánchez Núñez, Juan Manuel, Osthoff Rueda, Rodolfo, Jurkowska, Grazyna, Walczak, Michal, Malecka-Panas, Ewa, Linke, Krzysztof, Hartleb, Marek, Janssen-van Solingen, Gwendolyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210642/
https://www.ncbi.nlm.nih.gov/pubmed/25258162
http://dx.doi.org/10.1007/s40261-014-0233-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210642/
https://www.ncbi.nlm.nih.gov/pubmed/25258162
http://dx.doi.org/10.1007/s40261-014-0233-y

Ejemplares similares